North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 9 of 9
Details
LDL
Link Added : MHRA Drug Safety Update (Jan 2018): Recombinant human erythropoietins: very rare risk of severe cutaneous adverse reactions (SCARs) : https://www.gov.uk/drug-safety-update/recombinant-human-erythropoietins-very-rare-risk-of-severe-cutaneous-a
12/07/2023 09:05:06
(ebeavers )
UPD
sitematrix Changed from 0 to
03/05/2023 09:11:36
(rpaylor )
UPD
trafficCode Changed from AM to RD
03/05/2023 09:11:36
(rpaylor )
UPD
FurtherInformation Changed from
30, 50, 100, 120, 150, 200 & 250 microgram in 0.3ml and 360 microgram in 0.6ml injections in prefilled syringes.
Approved for use as a longer-acting alternative to darbepoetin in a
small numb
03/05/2023 09:11:36
(rpaylor )
UPD
Methoxy Polyethylene Glycol-Epoetin Beta (Mircera
®
, Pegzerepoetin
®
alfa) updated to red
03/05/2023 09:11:36
(rpaylor )
UPD
Methoxy Polyethylene Glycol-Epoetin Beta (Mircera
®
, Pegzerepoetin
®
alfa) b
01/02/2017 14:10:24
(WhitehallJ )
UPD
Methoxy Polyethylene Glycol-Epoetin Beta (Mircera
®
, Pegzerepoetin
®
alfa) b
23/01/2017 15:03:38
(DavidS )
UPD
Methoxy Polyethylene Glycol-Epoetin Beta (Mircera
®
, Pegzerepoetin
®
alfa) b
23/01/2017 15:03:28
(DavidS )
UPD
Methoxy Polyethylene Glycol-Epoetin Beta Build
30/11/2016 13:20:30
(ClarkH )